Arecor Therapeutics PLC Holding(s) in Company (1449V)
August 05 2022 - 10:33AM
UK Regulatory
TIDMAREC
RNS Number : 1449V
Arecor Therapeutics PLC
05 August 2022
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BMWLM973
Issuer Name
Arecor Therapeutics plc
UK or Non-UK Issuer
UK
2. Reason for Notification
An event changing the breakdown of voting
3. Details of person subject to the notification obligation
Name
Oxford technology 2 VCT Plc
City of registered office (if applicable)
Oxford
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Name City of registered office Country of registered office
Oxford Technology 2 VCT plc Oxford UK
=========================== ==============================
5. Date on which the threshold was crossed or reached
04-Aug-2022
6. Date on which Issuer notified
05-Aug-2022
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 5.208085 0.000000 5.208085 1587776
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 0.000000
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type Number of direct voting Number of indirect % of direct voting % of indirect voting
of shares ISIN rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
code(if possible) (DTR5.2.1)
GB00BMWLM973 1587776 5.208085 %
======================= ====================== ======================= =======================
Sub Total 8.A 1587776 5.208085 %
=============================================== ================================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights that may % of voting rights
instrument be acquired if the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ================================== ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
financial period settlement rights
instrument
Sub Total 8.B2
=========================================================== ===================== ==================
9. Information in relation to the person subject to the
notification obligation
1. Person subject to the notification obligation is not
controlled by any natural person or legal entity and does not
control any other undertaking(s) holding directly or indirectly an
interest in the (underlying) issuer.
Ultimate Name of controlled % of voting rights if it % of voting rights Total of both if it
controlling undertaking equals or is higher than through financial equals or is higher than
person the notifiable threshold instruments if it equals the notifiable threshold
or is higher than the
notifiable
threshold
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
05-Aug-2022
13. Place Of Completion
Oxford, UK
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUVUSRUBUWRAR
(END) Dow Jones Newswires
August 05, 2022 10:33 ET (14:33 GMT)
Arecor Therapeutics (LSE:AREC)
Historical Stock Chart
From Apr 2024 to May 2024
Arecor Therapeutics (LSE:AREC)
Historical Stock Chart
From May 2023 to May 2024